Stroke

Showing NaN - NaN of 35

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Florbetaben for Imaging of Vascular Amyloid

Recruiting
  • Acute Coronary Syndrome
  • +3 more
    • Ottawa, Ontario, Canada
      University of Ottawa Heart Institute
    Oct 13, 2023

    Atrial Fibrillation, Stroke, Bleeding Trial in Canada, Germany, United States (Antiplatelet-only strategy, Oral Anticoagulant

    Recruiting
    • Atrial Fibrillation
    • +2 more
    • Antiplatelet-only strategy
    • Oral Anticoagulant plus background antiplatelet therapy
    • Little Rock, Arkansas
    • +73 more
    Jan 12, 2023

    Stroke, Patent Foramen Ovale Trial in Canada, United States (Investigational PFO Closure Device, Standard of Care PFO Closure

    Enrolling by invitation
    • Stroke
    • Patent Foramen Ovale
    • Investigational PFO Closure Device
    • Standard of Care PFO Closure Device
    • Stanford, California
    • +11 more
    Dec 5, 2022

    Stroke, Atrial Fibrillation Trial in Canada, Denmark (Investigators can choose from one of four Non-vitamin K oral

    Recruiting
    • Stroke
    • Atrial Fibrillation
    • Non-vitamin K oral anticoagulant (NOAC)
    • Concord, New South Wales, Australia
    • +46 more
    Oct 21, 2022

    Atrial Fibrillation, Stroke Trial in Worldwide (Rivaroxaban, Acetylsalicylic acid)

    Recruiting
    • Atrial Fibrillation
    • Stroke
    • Canberra, Australian Capital Territory, Australia
    • +54 more
    Mar 23, 2022

    Stroke, Transient Ischemic Attack Trial in Ottawa (Computed Tomographic Angiogram)

    Completed
    • Stroke
    • Transient Ischemic Attack
    • Computed Tomographic Angiogram
    • Ottawa, Ontario, Canada
      The Ottawa Hospital
    Oct 7, 2021

    Stroke Trial in Ottawa (MRI perfusion imaging)

    Completed
    • Stroke
    • MRI perfusion imaging
    • Ottawa, Ontario, Canada
      The Ottawa Hospital
    Oct 7, 2021

    Atrial Fibrillation, Stroke Trial in Worldwide (Apixaban, aspirin)

    Active, not recruiting
    • Atrial Fibrillation
    • Stroke
    • Mesa, Arizona
    • +129 more
    Aug 25, 2021

    GLORIA-AF Registry Program - Second and Third Phases

    Completed
    • Stroke
    • Atrial Fibrillation
      • Mobile, Alabama
      • +665 more
      Mar 3, 2021

      Ischemic Attack, Transient, Stroke Trial in Edmonton, Ottawa (Dabigatran)

      Completed
      • Ischemic Attack, Transient
      • Stroke
      • Edmonton, Alberta, Canada
      • +1 more
      Jun 8, 2020

      Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )

      Completed
      • Stroke
      • +2 more
      • Birmingham, Alabama
      • +182 more
      Apr 14, 2020

      Stroke Trial in Canada, India (Dalteparin, Placebo)

      Unknown status
      • Stroke
      • Halifax, Nova Scotia, Canada
      • +7 more
      Feb 18, 2020

      The Ontario Neurodegenerative Disease Research Initiative

      Completed
      • Alzheimer Disease
      • +4 more
      • Observational Cohort
      • Hamilton, Ontario, Canada
      • +11 more
      Sep 23, 2019

      Stroke Trial in Ottawa (Virtual reality, Control)

      Completed
      • Stroke
      • Virtual reality
      • Control
      • Ottawa, Ontario, Canada
        Elisabeth Bruyère Hospital
      Jul 23, 2019

      Atrial Fibrillation, Stroke Trial in Worldwide (warfarin, Dabigatran dose 1, Dabigatran dose 2)

      Completed
      • Atrial Fibrillation
      • Stroke
      • Birmingham, Alabama
      • +983 more
      Apr 8, 2019

      Stroke, Atrial Fibrillation, Embolism Trial in Worldwide (warfarin tablets, Edoxaban tablets (high dose regimen-60mg), Edoxaban

      Completed
      • Stroke
      • +2 more
      • warfarin tablets
      • +4 more
      • Birmingham, Alabama
      • +1015 more
      Feb 8, 2019

      Stroke Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Acetylsalicylic acid (Aspirin, BAY1019036), Rivaroxaban-Placebo)

      Terminated
      • Stroke
      • Rivaroxaban (Xarelto, BAY59-7939)
      • +3 more
      • Tucson, Arizona
      • +453 more
      Dec 20, 2018

      Stroke, Transient Ischemic Attack, Atrial Fibrillation Trial in Canada (a 30-day ambulatory cardiac event monitor, 24-hour

      Unknown status
      • Stroke
      • +3 more
      • a 30-day ambulatory cardiac event monitor
      • 24-hour Holter
      • Calgary, Alberta, Canada
      • +16 more
      Oct 3, 2018

      Stroke Trial in Canada (rfVIIa, Standard saline solution)

      Completed
      • Stroke
      • rfVIIa
      • Standard saline solution
      • Calgary, Alberta, Canada
      • +14 more
      Oct 3, 2018

      Stroke Trial in Ottawa (iPad)

      Completed
      • Stroke
      • iPad
      • Ottawa, Ontario, Canada
        The Ottawa Hospital
      Sep 20, 2017

      Atherosclerosis, Stroke, Carotid Stenosis Trial in Canada, United States (Carotid Endarterectomy (CEA), Carotid Artery Stenting

      Completed
      • Atherosclerosis
      • +4 more
      • Carotid Endarterectomy (CEA)
      • Carotid Artery Stenting (CAS)
      • Birmingham, Alabama
      • +114 more
      Apr 13, 2017

      TIA, Stroke, Carotid Artery Stenosis Trial in Ottawa (PET/CT imaging with F-18 fluorodeoxyglucose)

      Terminated
      • TIA
      • +2 more
      • PET/CT imaging with F-18 fluorodeoxyglucose
      • Ottawa, Ontario, Canada
        The Ottawa Hospital, Civic Campus
      Apr 21, 2017

      Stroke Trial in Ottawa (virtual reality training, control)

      Completed
      • Stroke
      • virtual reality training
      • control
      • Ottawa, Ontario, Canada
        Elisabeth Bruyere Hospital
      Apr 11, 2017

      Stroke Trial in Worldwide (Desmoteplase, Placebo)

      Terminated
      • Stroke
      • Phoenix, Arizona
      • +151 more
      Feb 8, 2017

      Myocardial Infarction, Cardiovascular Death, Atherothrombosis Trial in Worldwide (Ticagrelor 90 mg, Ticagrelor 60 mg, Ticagrelor

      Completed
      • Myocardial Infarction
      • +3 more
      • Ticagrelor 90 mg
      • +2 more
      • Alexander City, Alabama
      • +846 more
      Dec 18, 2015